National Bank of Canada’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
N
National Bank of Canada's LLY Position: Q2 2026 in Review
National Bank of Canada increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $74M and bringing the position to 692,569 shares worth $831M. The position accounts for 0.59% of the portfolio, ranked #35.
National Bank of Canada first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 3,468 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- National Bank of Canada held 692,569 shares of Eli Lilly worth $831M as of Q2 2026.
- National Bank of Canada bought 72,391 Eli Lilly shares in Q2 2026, an estimated $74M.
- Eli Lilly made up 0.59% of National Bank of Canada's portfolio in Q2 2026, its #35 holding.
- National Bank of Canada first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 3,468 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.